NIH Federal Grant Awarded to Wildflower Biopharma
The National Institute of Health has rewarded a grant this fall to Wildflower Biopharma. The work/research is explained in the Grant Title: "Efficacy of a novel small-molecule splicing modulator in chronic lymphocytic leukemia (CLL)".
The Wildflower Team is excited to announce that the Grant work will be performed at BioLabs San Diego and in collaboration with Huidong Shi at the Department of Biochemistry and Molecular Biology at Augusta University, Georgia.
For inquiries or questions, please contact us at firstname.lastname@example.org
Recent PostsSee All
"An exon skipping screen identifies antitumor drugs that are potent modulators of pre-mRNA splicing, suggesting new therapeutic applications" Abstract: Agents that modulate pre-mRNA splicing are of in